Article Text

other Versions

PDF
Prognosis and management of chronic kidney disease (CKD) at the end of life
  1. Rachel Davison,
  2. Neil S Sheerin
  1. Renal Services, Freeman Hospital, Newcastle upon Tyne, UK
  1. Correspondence to Professor N S Sheerin, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; neil.sheerin{at}ncl.ac.uk

Abstract

The prevalence of chronic kidney disease (CKD) increases with age. As people are living longer, nephrologists are responsible for a progressively older cohort of patients with substantial comorbidities. Patients with CKD have a significant symptom burden and can benefit from intervention and symptom control from an early stage in the illness. It is also increasingly recognised that renal replacement therapy may not always offer an improvement in symptoms or a survival advantage to older patients with high levels of comorbidity. For these reasons, non-dialytic (conservative) management and end-of-life care is becoming part of routine nephrology practice. Such patients will also frequently be encountered in other specialities, requiring generalists to have some renal-specific skills and knowledge. Although there have been significant advances in this field in recent years, the optimum model of care and some of the care preferences of patients remain challenges that need to be addressed.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.